Bio-Techne Corporation (TECH)
NASDAQ: TECH · Real-Time Price · USD
61.68
-1.86 (-2.93%)
Dec 5, 2025, 4:00 PM EST - Market closed
Revenue by Geography
Fiscal year is July - June.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2013 - 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | 2013 - 2021 |
| United States Revenue | 673.46M | 683.23M |
Log In |
Log In |
Log In | Upgrade
|
| EMEA ex-UK Revenue | 272.37M | 266.31M |
Log In |
Log In |
Log In | Upgrade
|
| United Kingdom Revenue | 54.09M | 54.83M |
Log In |
Log In |
Log In | Upgrade
|
| APAC ex-Greater China Revenue | 78.29M | 77.26M |
Log In |
Log In |
Log In | Upgrade
|
| Greater China Revenue | 100.93M | 100.46M |
Log In |
Log In |
Log In | Upgrade
|
| Rest of World Revenue | 37.60M | 37.55M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Other) | -1.00K | - |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 1.22B | 1.22B |
Log In |
Log In |
Log In | Upgrade
|
Revenue
Fiscal year is July - June.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2013 - 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | 2013 - 2021 |
| Protein Sciences Revenue | 867.90M | 870.25M |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics and Genomics Revenue | 342.53M | 346.26M |
Log In |
Log In |
Log In | Upgrade
|
| Other Segment Revenue | - | 4.15M |
Log In |
Log In |
Log In | Upgrade
|
| Intersegment Revenue | -984.00K | -1.03M |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Other) | 7.29M | - |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 1.22B | 1.22B |
Log In |
Log In |
Log In | Upgrade
|
EBIT
Fiscal year is July - June.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2013 - 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | 2013 - 2021 |
| Protein Sciences Operating Income | 367.53M | 370.35M |
Log In |
Log In |
Log In | Upgrade
|
| Diagnostics and Genomics Operating Income | 25.93M | 21.32M |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Other) | -283.53M | -289.42M |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Total) | 109.93M | 102.26M |
Log In |
Log In |
Log In | Upgrade
|
Key Performance Indicators
Fiscal year is July - June.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2012 - 2020 |
|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | 2012 - 2020 |
| Organic Sales Growth | 5.00% |
Log In |
Log In |
Log In | Upgrade
|